Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedPublications section wording updated to clarify that publications are automatically filled from PubMed and may not be about the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding status notice on the page has been removed.SummaryDifference0.3%

- Check35 days agoChange DetectedNo substantive changes detected in the study record; core fields such as title, conditions, interventions, outcomes, eligibility, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check71 days agoChange DetectedThe page now displays Revision: v3.1.0 and removes multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a narrowing of content scope with a version update.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.